States Can Use the Coronavirus Response to Go After Insulin Price Gougers

April 9, 2020

The COVID-19 healthcare crisis is spreading beyond just those with the virus. As millions of Americans lose their jobs, they also stand to lose the employer-provided health insurance they rely on for life-saving drugs. Without insurance, the costs of those drugs can skyrocket. Insulin alone can cost $12,000 a year. So what can be done to keep insulin affordable during the crisis? One solution might come from a novel legal strategy that would test the limits of what constitutes illegal price gouging.

The articles on our website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice. The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the views or official position of Robins Kaplan LLP.


Related Publications

March 14, 2024
How Many Cases Have You Tried to a Verdict?
Gabriel Berg, Lauren Coppola - New York Law Journal
January 3, 2024
Navigating Class Actions After Papa John's Settlement Denial
Law360 - William Reiss, Ellen Jalkut, Laura Song
Fall 2023
All Is Not Lost: Personal Jurisdiction in a Post-BMS World
Meegan Hollywood, Jonathan Edelman - Antitrust Magazine
August 21, 2023
Colorado Expands Antitrust Protection
William Reiss and Ellen Jalkut - Colorado State Antitrust Act of 2023
August 7, 2023
Back to Top